Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands
申请人:Fukumoto Shoji
公开号:US20090253687A1
公开(公告)日:2009-10-08
The present invention relates to wherein each symbol is as defined in the specification. The compound has a superior mineral corticoidreceptorantagonistic action and is useful as an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like, a compound having a fused heterocycle, or a prodrug thereof, or a salt thereof; and an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like.